globalnews.ca
60%
149
Clinical trials start for VIDO’s COVID-19 vaccine candidate
COVID-19 vaccine candidate, with three people receiving an initial dose on Wednesday.The Canadian Center for Vaccinology says the first of 108 healthy adult volunteers received injections in Halifax. The placebo-controlled study will administer two doses to each volunteer, 28 days apart.“It’s a product of Canadian science, so it bodes well for the ability to make vaccines here.